FDA
approval
· 2021-03-03
FDA Approved: FOSAPREPITANT — Original Application (Avenacy, LLC)
Summary
FDA approved the original application for Fosaprepitant (fosaprepitant dimeglumine) by Avenacy, LLC, a generic antiemetic indicated to prevent chemotherapy-indu…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)